Search / 7 results found

  • Updated

FILE - In this Sunday, March 21, 2021, file photo, is a vial of of the AstraZeneca COVID-19 vaccine at the Guru Nanak Gurdwara Sikh temple, on the day the first Vaisakhi Vaccine Clinic is launched, in Luton, England. Anglo-Swedish drugmaker AstraZeneca has asked the U.S. Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19. The company said Tuesday, Oct. 5, 2021, that the treatment would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. (AP Photo/Alberto Pezzali, File)